Stryker (NYSE: SYK) today announced that it has launched its T2 Alpha femur retrograde nailing system.
Kalamazoo, Mich.–based Stryker designed the system as a data-driven nail design with an advanced locking screw option for axial stability.
“Stryker has made significant investments in the T2 Alpha Femur Retrograde Nailing System’s instrumentation platform,” Eric Tamweber, VP and general manager of Stryker’s Trauma business, said in a news release. “We are excited to now have a complete lower extremity T2 Alpha Nailing platform available for our surgeon customers.”
The system has a dedicated proximal targeting system to reduce the number of X-ray shots compared to freehand locking. The nails in the system are available in a broad range of sizes and radii of curvature to meet the unique needs of diverse anatomical patient needs.
